Tag: Show
-
Video visits show promise as way to cut allergy, asthma costs to employers – Employee Benefit News (registration)
Employee Benefit News (registration) Video visits show promise as way to cut allergy, asthma costs to employersEmployee Benefit News (registration)Many Americans think of allergies and asthma as chronic, yet only mildly harmful conditions. And, for some of the 7% of Americans that have asthma and 50 million Americans who experience seasonal allergies, that is true.…
-
Video visits show promise as way to cut allergy, asthma costs to employers – Employee Benefit News
Employee Benefit News Video visits show promise as way to cut allergy, asthma costs to employersEmployee Benefit NewsMany Americans think of allergies and asthma as chronic, yet only mildly harmful conditions. And, for some of the 7% of Americans that have asthma and 50 million Americans who experience seasonal allergies, that is true. But despite…
-
Asthma Awareness Month – Show How You Care About the Air – Environmental Defense Fund (blog)
Environmental Defense Fund (blog) Asthma Awareness Month – Show How You Care About the AirEnvironmental Defense Fund (blog)ChildAsthma May, which is well into ozone season in many regions in Texas, is also Asthma Awareness Month — an opportunity for the U.S. Environmental Protection Agency (EPA) and health partners to educate Americans on asthma health risks…
-
Five Ways to Show Love for Someone with Allergies or Asthma this Valentine’s Day – Newswise (press release)
Newswise (press release) Five Ways to Show Love for Someone with Allergies or Asthma this Valentine's DayNewswise (press release)Newswise — ARLINGTON HEIGHTS, ILL (January 19, 2016) –While we often think of over-the-top gifts on Valentine's Day, the true romantic can make a huge hit just by keeping a sweetheart's allergies and asthma in mind when…
-
57% babus fail lung capacity test, 48% show symptoms of asthma – Times of India
Hindustan Times 57% babus fail lung capacity test, 48% show symptoms of asthmaTimes of IndiaOf those examined, 48% had lung function suggestive of obstructive airway disease such as asthma and COPD (chronic obstructive pulmonary disease), 21% said they have frequent bouts of cough a few days in a month, and 8% felt their work is…
-
Statins Show Benefits, Limitations in Asthma – MD Magazine
MD Magazine Statins Show Benefits, Limitations in AsthmaMD MagazineA group of researchers reviewed the existing studies and clinical trials of statins used as a treatment for asthma to generate a list of recommendations for future studies. Dipanjan Bhattacharjee, of the Department of Pharmacology, at Kasturba Medical … View full post on asthma – Google News
-
UC Davis researchers show feasibility of using statins to treat asthma – News-Medical.net
News-Medical.net UC Davis researchers show feasibility of using statins to treat asthmaNews-Medical.netStatins continue to show that their benefits extend beyond their original focus of lowering high cholesterol. With the increasing prevalence of asthma, scientists are studying the effects of statins in the lungs. In a new study in Physiological Reports …and more » View full post…
-
New asthma therapy? Approved drugs show promise – Futurity: Research News
Design & Trend New asthma therapy? Approved drugs show promiseFuturity: Research NewsResearchers have identified the potential root cause of asthma and are testing a class of drugs—initially developed to treat osteoporosis—that may reverse symptoms. “Our findings are incredibly exciting,” says Daniela Riccardi, a professor from …Asthma Could Be Cured Within Five YearsDesign & TrendScientists Have…
-
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function … – PR Newswire (press release)
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function …PR Newswire (press release)HOUSTON, Feb. 21, 2015 /PRNewswire/ — Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat® inhaler from five Phase III trials from the UniTinA-asthma® program at the 2015 American Academy of Allergy, … View full post on asthma –…
-
Mepolizumab Relieves Severe Asthma, Trials Show – Medscape
Medscape Mepolizumab Relieves Severe Asthma, Trials ShowMedscapeMUNICH, Germany — The monoclonal antibody mepolizumab delivered subcutaneously is a promising treatment for patients with severe eosinophilic asthma, according to the results of 2 new studies presented here at the European Respiratory Society …and more » View full post on asthma – Google News